# Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion

> **NCT07573163** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Alaa Sada** · enrollment: 34 (estimated)

## Conditions studied

- Mild Autonomous Cortisol Secretion (MACS)
- Adrenalectomy; Status

## Interventions

- **DRUG:** Tirzepatide
- **OTHER:** Standard medical treatment

## Key facts

- **NCT ID:** NCT07573163
- **Lead sponsor:** Alaa Sada
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07573163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07573163, "Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07573163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*